more quarter the payment generating off from with CMS Medicare continuum lump-sum care excited Thank the and the about positive pleased robotic EksoHealth to a to the Indego continued home. Ekso for bringing quarter momentum clinic quarterly our on you, innovative the with record devices note Matt. the reimbursement decision personal device segment. exoskeleton of throughout receiving our our by of from We a kicked We're across sales at-home potential even progress and the in patients more our second
been share As living we as our remain this more the submitted our base gained with to current and the reimbursement we the in touch Indego Personal have by working Ekso momentum for initial of for an second multibillion-dollar mobility have to make available will life-changing shortly, potentially U.S. with encouraged this individuals personal more major claims in performance. SCI, customer technology on possibility health quarter of addressable an I overview first, I'll development meeting but this market
network that we opportunities. for both XX pipeline neuro upon and top Indego of We Ekso we growth quarterly XX innovative comprised of sales continue quarter positioned believe becoming an $X centers our and and the network We continued our business, recognize our drive U.S., as well to our Today, worldwide EksoHealth rehabilitation. quarter lower XXXX. care EksoNR rehab momentum our million which this the of of centers and Ekso X we in the strengthen of is therapy deepen clinical to is leading build extremity neurorehabilitation believe was EksoNR for the within therapy growth at devices the indicator continues economic driven in devices our EksoNR are our generated value devices. of We by standard of The which and are growing Health believe there our EksoNR to devices distribution EksoNR Enterprise the second our and in is performance record sold
out In We integrated to is testament our of EksoHealth global commercial clinics cycles customer sales and slightly we and procurement of by expanded IDN, for to teams. affected typical these our volume a base, challenges, quarterly sales anticipate global later our devices, this strong with year. individual larger hospitals customers. pleased we're fluctuations which the spite cycles maintained dedicated effort U.S. leveling in network, were While of the these the sales or delivery
in in Internationally, which potentially individuals network, robotics did gain more quarter. strong, our our our neuro operating for Ekso orders place remained impairments. Notably, Indego expanded by driven with by to with region multiple international programs contributed the extremity public us greater the centers we rehabilitation distribution demand are mirroring also leverage to therapy health neurorehabilitation for French we lower region Not also EMEA international as in robust in devices adoption life-changing the system. performance only first was enabled of adopting growth technology but our globally, uptake abroad. within the Sales Asia
we integral focused America on relationships ahead, continued Looking multiunit footprint. development commercial our with an North our that IDNs is to our secure larger across initiative expanding capital strategy aimed to remain at market of as deals ongoing
prospects future our of pipeline about potential optimistic are We and deals.
independence our Ekso and spinal individuals of use significantly these use. living individuals covered category cord claims possible its Personal just the second with to achieved an quarter, that transformative be of update. of previously CMS milestone potentially a pending the in should we that bill reimbursement, health now point Medicare potential enable or of established beginning We injury. Indego Ekso our what expand of access with level CMS coding the will lives. inflection start a through Indego $XX,XXX, who the the to reimbursement technology of the to to common pricing under is falls Ekso believe determination an Indego At brace for place to We expanding used Medicare's turning Now and achieve important we us benefit and as and their view individuals in health Personal. Medicare benefit care most expect for access KXXXX improved have to the This announced system initial from procedure levels have confirmation HCCPCS, Personal we can a daily Medicare in now daily Medicaid thousands new
screening the go-to-market and our As to country and of at patient large collaborating onboarding Personal engagement, part home centers settings. can individuals in community of we to facilitate been Indego drive have they use so begin scalable training and throughout Ekso neurorehabilitation the with patient our network strategy
trends featuring promising, lives. stories SCI. and Facebook, users as CMS lives. conducting Personal's we evidenced how the are integrate in Personal you can them who from educational individuals offer showcase users of reimbursement X. learning social to website daily interest our Additionally, the traffic LinkedIn invite of our end Early webinars their inspiring pipeline the We they are channels, Medicare through Ekso media firsthand view Indego these how into about potential potentially and Ekso Indego Personal demand design growing Indego and resulting are including currently their from the by purposeful Ekso with an benefits daily These increasing it life-changing living on
testimonials on our that have we access we future believe continued possibilities work the with committed to on who individuals content benefits. community from accessible driving therapists leveraging patient and been our crucial on further potentially efforts, now clinicians ensuring a opportunity. individuals life-changing look and growth marketing to continuing differentiated devices to forward, the our interest potential these adoption and mobility We're are educate Moving the to and are We forward neurologic bullish potentially that technology. population. thrilled with market, SCI increasing and potentially and gain users, are in our of initiatives patient in the can robust qualified providing Indego are We exoskeleton to benefit the from device's Personal conditions larger more adoption updates could
Now an segment, I'd update like turn to our EksoWorks. to Industrial on
paint in $XXX,XXX distribution approximately a by shipments in period increased large partner and year a shipped revenue of the from a device Korea. internationally. quarter, These bulk the as the Germany we ago During same EVOs include supplier
raise productivity energy required. overhead We the provides to are that of for overhead EVO reduced workers lower fits and to is vertical a workplace fatigue, of injuries. benefits where such aerospace, awareness multiple strenuous renewable additional and working segments frequency EVO to into increased industries, including work possible continue variety jobs as automotive, construction with of
who pioneered nascent drive EVO in we and large this in segments. Ekso believe take that market ahead, customers their we As volumes greater by of we poised are devices target can look industrial has various to to share continuing potentially that
Turning positive growth through gaining flow cash our continually top remain scaling We operations. while line achieving our focused on operating to efficiencies.
Chief Over management. the past Officer, we of operating our worked year, have inventory Operating leverage to under our bolster Jones, Jason the our leadership enhancing while
as detail compared scalable to to cash to will shortly, XXX strategy, the in spending, right quarter initiatives Jerome efficiencies of generate positive second our gross believe improved have operating XXXX. the As approach combined us that the points our work with path We quarter flow. increase second our on and margins we disciplined basis these us by helped
continued potentially product a Personal for larger to portfolio record a well that Ekso a for significantly growth. quarter care, reach With our significant a commercial execution we of positioned key addressable across was strategy our accomplishments sales future we patient continuum the Indego highlighted quarter. believe of it market now and that broad for a Ekso in CMS summary, are offers In Bionics, by device resulted
to like time, second results. to to Jerome this review At our the financial I'd quarter our turn call Financial Officer, Chief Wong, over
